Table 1.
Demographic characteristics of patients with invasive infection due to MRSA with vancomycin MICs of 2 μg/ml from 5 U.S. statesa
| Demographic characteristic | n (%) | Median | Range |
|---|---|---|---|
| Age (yr) | 61 | 0–97 | |
| Male | 85 (62) | ||
| Race | |||
| White | 62 (45) | ||
| Black | 55 (40) | ||
| Other | 10 (7) | ||
| Unknown | 11 (8) | ||
| U.S. state | |||
| GA | 30 (22) | ||
| TN | 21 (15) | ||
| MN | 13 (9) | ||
| CA | 39 (28) | ||
| NY | 35 (25) | ||
| Underlying condition | |||
| HIV | 4 (3) | ||
| Diabetes | 69 (50) | ||
| Chronic renal failure | 51 (37) | ||
| Dialysis (past yr) | 28 (20) | ||
| Chronic liver disease | 9 (7) | ||
| Immunosuppressive therapy | 10 (7) | ||
| Solid-organ malignancy | 17 (12) | ||
| Hematologic malignancy | 2 (2) | ||
| Resident in a long-term care facility in yr prior to initial culture | 42 (30) | ||
| Past MRSA infection or colonization | 45 (33) | ||
| Surgery in yr prior initial culture | 65 (47) | ||
| Hospitalized in yr prior to initial culture | 90 (65) |
a
Data from the Active Bacterial Core Surveillance for Invasive MRSA Project (n = 138).